{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pharmacology: Spina Bifida and Urinary Tract Infection Management
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- Choose the guidelines for nonpharmacologic management of neurogenic bladder in patients who have spina bifida.
- Select the recommendations for pharmacologic management of neurogenic bladder and bowel in patients who have spina bifida.
- Identify the surgical options for patients whose neurogenic bladder cannot be managed adequately with pharmacologic treatment.
Learning Outcomes
Seventy-five percent of participants will demonstrate competency in clinical reasoning regarding the management of neurogenic bladder in patients who have spina bifida by achieving a minimum score of 70% on the outcomes based posttest.Disclosures
All authors and planners have no relevant financial relationships with any ineligible organizations regarding this activity.
Price:
$21.95
Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: JPSN0123
Published: Jan/Mar 2023
Expires: 3/6/2026
Required Passing Score: 7/10 (70%)